Fulcrum Therapeutics, Inc. (FULC)
NASDAQ·Healthcare·Biotechnology
$3.80
+0.13%
Mkt Cap $289.93M
Analyst Ratings
Buy
0
Hold
3
Sell
2
Price Target (31 analysts)
$3.60
Range $3.00 – $4.00
Implied Upside
-5.3%
Consensus $3.60 vs current $3.80
NASDAQ·Healthcare·Biotechnology
$3.80
+0.13%
Mkt Cap $289.93M
Buy
0
Hold
3
Sell
2
Price Target (31 analysts)
$3.60
Range $3.00 – $4.00
-5.3%
Consensus $3.60 vs current $3.80